Phase II trial of bortezomib plus doxorubicin in hepatocellular carcinoma (E6202): a trial of the Eastern Cooperative Oncology Group

Overview of attention for article published in Investigational New Drugs, June 2014

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

patent: 2 patents

Readers on

mendeley: 33 Mendeley

So far, Altmetric has seen 2 patents that reference this research output.

Prodrug platform useful to deliver amines, amides and phenols

Grant US-12486292-B2

United States of America

A PRODRUG PLATFORM USEFUL TO DELIVER AMINES, AMIDES AND PHENOLS

Application US-20220281904-A1

United States of America

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity.